117829-67-1 ((Caerulein,1-de(5-oxo-L-proline)-2-L-arginine-5-L-valine- (9CI))

Caerulein,1-de(5-oxo-L-proline)-2-L-arginine-5-L-valine- (9CI);Bolton Hunter-cholecystokinin nonapeptide;3-(4-Hydroxy-(125I)iodophenyl)proprionyl-(34-thr-37-nle)cck(31-39);BH-Cck-9;Caerulein, 1-de(5-oxo-L-proline)-2-L-arginine-5-L-valine-;Caerulein, 1-de(5-oxo-proline)-2-arginine-5-valine- (9CI);N~5~-(diaminomethylidene)-L-ornithyl-L-alpha-aspartyl-O-sulfo-L-tyrosyl-L-valylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide;DTXSID60151926;117829-67-1;Caerulein, 1-de(5-oxo-proline)-2-arginine-5-valine-;BH-CCK9;

XABUVDVSEMIDIN-QOHRKOJGSA-N

1S/C55H74N14O17S2/c1-29(2)46(69-53(81)39(23-31-15-17-33(18-16-31)86-88(83,84)85)67-52(80)41(25-44(71)72)66-48(76)35(56)13-9-20-60-55(58)59)54(82)62-28-43(70)63-40(24-32-27-61-36-14-8-7-12-34(32)36)50(78)64-37(19-21-87-3)49(77)68-42(26-45(73)74)51(79)65-38(47(57)75)22-30-10-5-4-6-11-30/h4-8,10-12,14-18,27,29,35,37-42,46,61H,9,13,19-26,28,56H2,1-3H3,(H2,57,75)(H,62,82)(H,63,70)(H,64,78)(H,65,79)(H,66,76)(H,67,80)(H,68,77)(H,69,81)(H,71,72)(H,73,74)(H4,58,59,60)(H,83,84,85)/t35-,37-,38-,39-,40-,41-,42-,46-/m0/s1

S(C)CC[C@@H](C(N[C@H](C(N[C@H](C(N)=O)CC1C=CC=CC=1)=O)CC(=O)O)=O)NC([C@H](CC1=CNC2C=CC=CC1=2)NC(CNC([C@H](C(C)C)NC([C@H](CC1C=CC(=CC=1)OS(=O)(=O)O)NC([C@H](CC(=O)O)NC([C@H](CCC/N=C(\N)/N)N)=O)=O)=O)=O)=O)=O